Bikanta - About the company
Bikanta is a seed company based in Berkeley (United States), founded in 2013. It operates as a Molecular diagnostics and optical imaging products for advanced medical solutions. Bikanta has raised $120K in funding from Y Combinator. The company has 497 active competitors, including 170 funded and 95 that have exited. Its top competitors include companies like Caris Life Sciences, Geneoscopy and 4baseCare.
Company Details
Molecular diagnostics and optical imaging products for advanced medical solutions. The company develops advanced products for medical diagnostics and optical imaging, addressing questions at the molecular and cellular level. They are committed to scientific rigor, ethics, innovation, and providing hope for patients battling debilitating diseases. Their focus is on extending the physician's reach to the cellular level and redefining the limits of optical imaging. They aim to bring advanced solutions to market, impacting medical diagnostics. They are involved in biotechnology and offer products and services related to medical diagnostics and optical imaging. They are focused on innovation and advanced technology in the medical field.
- Website
- bikanta.com
- Social
- Email ID
- *****@bikanta.com
- Phone Number
- +1 **********
Key Metrics
Founded Year
2013
Location
Berkeley, United States
Stage
Seed
Total Funding
$120K in 1 round
Latest Funding Round
Investors
Ranked
203rd among 497 active competitors
Employee Count
4 as on May 31, 2026
Similar Companies
Legal entities associated with Bikanta
Bikanta is associated with 1 legal entity given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
|---|---|---|---|---|
BIKANTA CIN: 463964356 , United States, Active | Dec 31, 1999 | - | 3 (As on Dec 31, 2017) | - |
Sign up to download Bikanta's company profile
Bikanta's funding and investors
Bikanta has raised a total funding of $120K over 1 round. Its latest funding round was a Seed round on Jul 16, 2014 for $*****. 1 investor participated in its latest round. Bikanta has 6 institutional investors.
Here is the list of recent funding rounds of Bikanta:
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Jul 16, 2014 | 7286290 | Seed | 3652126 | 8647708 | 6631031 | 6343105 |
Access funding benchmarks and valuations. Sign up today!View details of Bikanta's funding rounds and investors
Bikanta's founders and board of directors
Founder? Claim ProfileBikanta's employee count trend
Bikanta has 4 employees as of May 26. Here is Bikanta's employee count trend over the years:
Uncover Bikanta's growth story! Sign up today!
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Bikanta's Competitors and alternates
Top competitors of Bikanta include Caris Life Sciences, Geneoscopy and 4baseCare. Here is the list of Top 10 competitors of Bikanta, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Caris Life Sciences 1996, Irving (United States), Public | Developer of panomic disease profiling technologies for cancer precision medicine | $1.23B | 70/100 | |
2nd | Geneoscopy 2015, St. Louis (United States), Series C | Developer of non-invasive biomarker tests for colorectal cancer | $219M | 67/100 | |
3rd | Provider of precision oncology solutions, including genomic testing and digital health | $25.9M | 67/100 | ||
4th | Intellia Therapeutics 2014, Cambridge (United States), Public | Developer of therapeutics based on CRISPR/Cas9 technology for multiple diseases | $85M | 66/100 | |
5th | Personalis 2011, Menlo Park (United States), Public | Provider of genomic sequencing and diagnosis software for the healthcare industry | $87.3M | 65/100 | |
6th |  Deep Genomics 2014, Toronto (Canada), Series C | AI-powered platform for RNA biology to accelerate genetic therapy discovery | $238M | 63/100 | |
7th | Precipio Diagnostics 1997, New Haven (United States), Public | Provider of cancer diagnostics and second opinion tools | $800K | 63/100 | |
8th | NeoGenomics 2002, Fort Myers (United States), Public | Provider of cancer genetic diagnostic services | - | 63/100 | |
9th |  Adela 2021, San Francisco (United States), Series A | Developer of a platform for detection of cancer | $139M | 62/100 | |
10th |  UniQure 1998, Amsterdam (Netherlands), Public | Developer of gene-based therapies for patients with genetic or acquired diseases | $111M | 62/100 | |
203rd | Bikanta 2013, Berkeley (United States), Seed | Molecular diagnostics and optical imaging products for advanced medical solutions | $120K | 34/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on Bikanta's competitors? Click here to see the top ones
Bikanta's Investments and acquisitions
Bikanta has made no investments or acquisitions yet.
Reports related to Bikanta
Here is the latest report on Bikanta's sector:
News related to Bikanta
•
Get curated news about company updates, funding rounds, M&A deals and others. Sign up today!Are you a Founder ?
FAQs about Bikanta
Explore our recently published companies
- Bandhan TMX - Bhavnagar based, 2004 founded, Unfunded company
- Schauenburg - South Africa based, Unfunded company
- Proyector24.es - Barcelona based, Unfunded company
- Women Fitness - Agra based, 2000 founded, Unfunded company
- Dr. Reddy's in Netherlands - Netherlands based, 1984 founded, Public company
- Slummy Single Mummy - Taunton based, 2009 founded, Unfunded company
